Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Pooja, Advani"'
Autor:
Yousif M. Abdelmoneim, MD, Yanyan Lou, MD PhD, Pooja Advani, MD, Andras Khoor, MD PhD, Akash Sharma, MD, Ephraim E. Parent, MD PhD
Publikováno v:
Radiology Case Reports, Vol 20, Iss 1, Pp 801-804 (2025)
Breast carcinomas are well known for expression of estrogen receptor (ER) however there are other malignancies that are also express ER, possibly confounding the diagnostic interpretation of 16α-[18F]fluoro-17β-estradiol (FES; Cerianna GE HealthCar
Externí odkaz:
https://doaj.org/article/8bd3e53b6fa14942ac35b0cde23a8f94
Autor:
Umair Majeed, Tudor Puiu, Jason Sluzevich, Gina Reynolds, Marites Acampora, Alvaro Moreno-Aspitia, Katherine J. Bodiford, Pooja Advani
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Alpelisib is a PIK3a inhibitor approved for the treatment of metastatic ER+ breast cancer in combination with fulvestrant. Although rash is a common side effect of this medication, we present the first case of drug reaction with eosinophilia and syst
Externí odkaz:
https://doaj.org/article/e8c1359fb89447618c412fdd3e63f7c0
Autor:
Cindy, Tofthagen, Adam, Perlman, Pooja, Advani, Brenda, Ernst, Judith, Kaur, Winston, Tan, Katharine, Sheffield, John, Crump, Joshua, Henry, Jason, Starr
Publikováno v:
Journal of Palliative Medicine. 25:1563-1570
biBackground:/i/bThirty-six states, including Florida, have legalized marijuana for medical and/or recreational use, yet how it is used and perceived by persons with cancer is not well understood.biObjectives:/i/bThe purpose of this study was to iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479a1f926d50658d1ba069fd6dd39a0e
https://doi.org/10.1089/jpm.2022.0100
https://doi.org/10.1089/jpm.2022.0100
Autor:
Constance Visovsky, Victoria K. Marshall, Maria Moreno, Pooja Advani, Dawn Mussallem, Cindy Tofthagen
Purpose: The purpose of this phenomenological study was to gain an understanding of the intersection of continued treatment and quality of life in women living with metastatic breast cancer (MBC). Methods: This was a qualitative study in which women
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ec553e763786c3a375cf66585f8ce22
https://doi.org/10.21203/rs.3.rs-2833645/v1
https://doi.org/10.21203/rs.3.rs-2833645/v1
Autor:
Mizba Baksh, Aaron Spaulding, Alexander Hochwald, Hodge David, Sikander Ailawadhi, Pooja Advani
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:HSR22-126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::652c4de8823fcf8823580b2fc88c03f4
https://doi.org/10.6004/jnccn.2021.7195
https://doi.org/10.6004/jnccn.2021.7195
Autor:
William A. Hammond, Pooja Advani, Rhett P. Ketterling, Daniel Van Dyke, James M. Foran, Liuyan Jiang
Publikováno v:
Case Reports in Hematology, Vol 2018 (2018)
Updated WHO criteria define mixed phenotype acute leukemia (MPAL) with more stringent diagnostic criteria than the formerly described entity biphenotypic acute leukemia (BAL). The changes in diagnostic criteria influence management by assigning weigh
Externí odkaz:
https://doaj.org/article/23995debc8a248129a8fcd32a98a821d
Autor:
Saranya Chumsri, Joseph J. Larson, Kathleen S. Tenner, Jun He, Mei-Yin Polley, Morgan T. weidner, Amanda N. Arnold, Dana Haley, Pooja Advani, Kostandinos Sideras, Alvaro Moreno-Aspitia, Edith A. Perez, Keith L. Knutson
Publikováno v:
Cancer Research. 83:P4-01
Background: Previous studies demonstrated that activation of the RAS/MAPK pathway is associated with reduced tumor-infiltrating lymphocytes and poor response to neoadjuvant chemotherapy in triple-negative breast cancer (TNBC). Further in vivo study s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::982691b27c7cf7cf4641ea35a90d4544
https://doi.org/10.1158/1538-7445.sabcs22-p4-01-17
https://doi.org/10.1158/1538-7445.sabcs22-p4-01-17
Autor:
Nusrat Jahan, Jodi Taraba, Karthik V. Giridhar, Roberto A. Leon-Ferre, Amye J. Tevaarwerk, Elizabeth Cathcart-Rake, Ciara C. O’Sullivan, Prema Peethambaram, Timothy J. Hobday, Kathryn Ruddy, Lida A. Mina, Pooja Advani, Felipe Batalini, Matthew P. Goetz, Tufia C. Haddad, Fergus J. Couch, Siddhartha Yadav
Publikováno v:
Cancer Research. 83:P4-01
Background: Two poly (adenosine diphosphate-ribose) polymerase inhibitors (PARPi) are currently FDA-approved for the treatment of HER2-negative metastatic breast cancer (MBC) in carriers of germline pathogenic variants (PVs) in BRCA1 or BRCA2 (BRCA1/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47f55de786e6ac1644ca85093aa8726c
https://doi.org/10.1158/1538-7445.sabcs22-p4-01-22
https://doi.org/10.1158/1538-7445.sabcs22-p4-01-22
Publikováno v:
Breast Journal. Jun2020, Vol. 26 Issue 6, p1185-1188. 4p.
Publikováno v:
Annals of Nuclear Medicine
Background mRNA COVID-19 vaccines are known to provide an immune response seen on FDG PET studies. However, the time course of this metabolic response is unknown. We here present a temporal metabolic response to mRNA COVID-19 vaccination in oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::573369b3eac6f91a2f11eddd872ac99e
https://doi.org/10.1007/s12149-021-01675-8
https://doi.org/10.1007/s12149-021-01675-8